3004.90.92.56 - Containing famotidine or its salts 🖩
Details
| Field | Value |
|---|---|
| Unit of Quantity | kg |
| General Rate of Duty (Column 1 - General) | Free |
| Special Rate of Duty (Column 1 - Special) | N/A |
| Column 2 Rate of Duty | 30% |
| Quota Quantity | N/A |
| Additional Duties | N/A |
Overview
This HTS category, 3004.90.92.56, specifically classifies medicaments containing famotidine or its salts. Famotidine is a histamine H2-receptor antagonist widely used to reduce the production of stomach acid, making it effective in treating conditions such as heartburn, acid indigestion, and peptic ulcers. The classification applies to these products when they are presented in measured doses or in forms and packings suitable for retail sale, intended for therapeutic or prophylactic purposes.
This specific classification distinguishes itself from its siblings by its active pharmaceutical ingredient. For instance, it is separate from 3004.90.92.50 (Laxatives) and 3004.90.92.55 (Antacids) based on the pharmacological action of famotidine, which primarily targets acid suppression rather than bowel motility or direct neutralization of stomach acid. It also differs from 3004.90.92.57, which covers medicaments containing pantoprazole, another proton pump inhibitor but a distinct active ingredient.
As this HTS code represents a leaf node, there are no further subcategories under 3004.90.92.56. The classification is definitive for medicaments containing famotidine or its salts when prepared for therapeutic or prophylactic uses and packaged for direct consumer use. The precise form of the product, whether tablets, capsules, oral solutions, or injectable forms, does not alter the classification as long as famotidine is the primary active ingredient and it meets the general criteria of Chapter 30.